Press release
U.S. Pharmacogenomics Market Size Set to Hit USD 5.6 Billion by 2031 with a CAGR of 8.7%: AMR
U.S. Pharmacogenomics Market
The U.S. pharmacogenomics market is experiencing significant growth due to several driving factors. Firstly, advancements in genomic research and technology have enabled personalized medicine approaches, which utilize genetic information to determine the most effective treatments for individuals. This has increased the demand for pharmacogenomics testing and analysis. Secondly, growing awareness among healthcare professionals and patients about the potential benefits of pharmacogenomics in optimizing drug therapy is driving adoption. Additionally, the rising prevalence of chronic diseases and the need for more targeted therapies further fuel the market growth. Moreover, supportive government initiatives, increasing investment in research and development, and collaborations between pharmaceutical companies and research institutions are contributing to the market expansion.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/47832
๐๐จ๐ฉ ๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Thermo Fisher Scientific Inc.
โข Illumina, Inc.
โข F. Hoffmann-La Roche Ltd.
โข QIAGEN
โข Agilent Technologies, Inc.
โข Eurofins Scientific
โข Bio-Rad Laboratories, Inc.
โข Danaher Corporation
โข Becton, Dickinson and Company
โข Myriad Genetics, Inc.
๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
The pharmacogenomics market can be segmented based on technology, application, end-user, and region. Here's a brief overview:
By Technology
โข Next Generation Sequencing
โข Polymerase Chain Reaction
โข Gel Electrophoresis
โข Mass Spectrometry
โข Microarray
โข Others
By Application
โข Cardiovascular Diseases
โข Infectious Diseases
โข Oncology
โข Neurological Diseases
โข Psychiatry
โข Others
By End User
โข Hospitals & Clinics
โข Research Institutions
โข Academic Institutes
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/47832
Key Findings Of Study
โข By technology, the polymerase chain reaction segment was the highest contributor to the U.S. Pharmacogenomics Market in 2021.
โข Depending on application, the oncology segment dominated the U.S. Pharmacogenomics Market in 2021, and is expected to continue this trend during the forecast period.
โข Depending on end user, the hospitals & clinic segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Pharmacogenomics Market Size Set to Hit USD 5.6 Billion by 2031 with a CAGR of 8.7%: AMR here
News-ID: 3374423 • Views: โฆ
More Releases from Allied Market Research (AMR)
Revolutionizing Healthcare: Medical Cannabis Market Projected to Reach USD 53.88 โฆ
Allied Market Research published a report, titled, "Medical Cannabis Market by Product Type (Buds/Marijuana Flower and Cannabis Extracts), Application (Chronic Pain, Mental Disorders, Cancer, and Others), and End User (Pharmaceutical and Research & Development Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global medical cannabis industry generated USD 6.82 billion in 2020 and is expected to reach USD 53.88 billion by 2030, witnessing a CAGRโฆ
Healthcare Fraud Detection Market Updates : Projected to Attain USD 3.6 Billion โฆ
According to a new report published by Allied Market Research, titled, "Healthcare Fraud Detection Market," the healthcare fraud detection market was valued at $1.1 billion in 2021, and is estimated to reach $3.6 billion by 2031, growing at a CAGR of 12.6% from 2022 to 2031.
Healthcare or medical fraud involves making false statements or misrepresentations about medical bills, healthcare funds, or the nature of medical treatments or services provided, leadingโฆ
Technical Textile Market Size, Growth Drivers and Strategic Analysis Through 203 โฆ
According to a recent report published by Allied Market Research, titled "Technical Textile Market by Material, Process, and End-Use Application: Global Opportunity Analysis and Industry Forecast, 2023-2032", the global technical textile market was valued at $191.7 billion in 2022 and is projected to reach $331.8 billion by 2032, registering a CAGR of 5.7% during the forecast period.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1841
Market Growth Drivers:-
- The growth of the globalโฆ
Protective Clothing Market Outlook 2026-2033 Industry Size, Segmentation, Key Pl โฆ
Allied Market Research has published a comprehensive report titled "Protective Clothing Market by Material Type, Application, and End-use Industry: Global Opportunity Analysis and Industry Forecast, 2024-2033." According to the study, the global protective clothing market was valued at $10.3 billion in 2023 and is projected to reach $18.6 billion by 2033, registering a CAGR of 6.1% during the forecast period.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/371
Market Growth Drivers and Challenges:
-โฆ
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
โข F. Hoffmann-la Roche Ltd
โข Abbott
โข Oxford Nanopore Technologies
โข Thermo Fisher Scientific Inc.
โข Illumina, Inc.
โข QIAGEN
โข Agilent Technologies, Inc.
โข Myriad Genetics, Inc.
โข Admera Health
Contact Us:
If you have any queries aboutโฆ
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 toโฆ
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis ofโฆ
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with theirโฆ
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complexโฆ
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certainโฆ
